The Management Challenges of Antithrombin Deficiency in Pregnancy
To view this Webinar, please scroll down to the bottom of the page.
This is a recorded version of our webinar on addressing the management challenges of antithrombin deficiency in pregnancy, presented by Dr. Andra H. James and Dr. Barbara Konkle that took place on June 27, 2017. This webinar was jointly sponsored by the Creighton University Health Sciences Continuing Education program and the Foundation for Women & Girls with Blood Disorders. The production and archiving of this program were made possible in part by an educational grant from Grifols.
This Webinar will bring together two leading experts in the area of Antithrombin (AT) deficiency and its obstetric and hematologic management who will disseminate the consensus of our previously held meeting, on the correct diagnosis and the optimal treatment and management of women with AT deficiency during pregnancy and in the postpartum period.
After completing this educational activity, participants should be able to:
- Describe the laboratory assessment of antithrombin deficiency.
- Discuss and describe the background on the maternal and fetal consequences of antithrombin deficiency.
- Describe the optimal treatment and management of patients with antithrombin deficiency in pregnancy
Andra H. James, MD, MPH
Consulting Professor, Obstetrics & Gynecology
Duke University Medical Center
Associate Chief Scientific Officer
Director, Hemostasis, Platelet Immunology and Genomics Laboratory
Associate Director, Bleeding Disorders Program of Washington
Professor of Medicine/Hematology
University of Washington School of Medicine